Vibrating Mesh Nebulizers

Vibrating Mesh Nebulizers

The vibrating mesh nebulizer market is a rapidly growing industry that involves the production and distribution of devices designed to turn liquid medication into a fine mist that can be inhaled by patients. The market is driven by a number of factors, including the increasing prevalence of respiratory diseases, the aging population, and the growing demand for portable and convenient medical devices. One of the key trends in the vibrating mesh nebulizer market is the increasing use of technology to improve the efficiency and effectiveness of nebulizers. For example, some nebulizers now come equipped with Bluetooth connectivity, allowing patients to track their medication usage and receive reminders to take their medication. Other nebulizers use advanced algorithms to adjust the mist output based on the patient's breathing rate and other factors. Many companies are developing nebulizers that are lightweight and easy to transport, making them ideal for patients who travel frequently or have mobility issues. Additionally, some nebulizers now come with built-in timers and alarms, allowing patients to take their medication at the right time and avoid missed doses.

The Vibrating Mesh Nebulizers Market is expected to grow at a strong CAGR of 9.2% during the forecast period owing to increasing geriatric population. The rise in the geriatric population is driving the mesh nebulizer market for several reasons. As people age, they are more likely to develop respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia. These conditions can make it difficult to breathe, and may require the use of medication in the form of a fine mist that can be inhaled through a nebulizer. As of 2019, the WHO reported that by 2050, one in five people in the world will be over 60. That would be approximately 2 billion elderly individuals, up from 900 million in 2015.

• Based on the type, the market is bifurcated into active mesh nebulizers and passive mesh nebulizers. The active mesh nebulizers held dominant share of the market in 2022. Some of the driving factors for active mesh nebulizers include their ease of use and administration, compact and portable design, multiple medication options, high drug delivery efficiency, low noise operation, FDA-approval and safety, suitability for both adults and children, and reduced risk of contamination and cross-contamination. These features make active mesh nebulizers a popular choice for patients who require medication therapy at home or in a healthcare setting.
• By application, the market is categorized into COPD, asthma, cystic fibrosis, and others. Asthma is anticipated to grow with high CAGR during the forthcoming period. According to the World Health Organization (WHO), asthma is estimated to affect over 262 million people globally, and it is one of the leading causes of disability and death. In US, asthma is estimated to affect over 25 million people, or about 8% of the population. The report of the Asthma and Allergy Foundation of America stated that around 9.7% of female grown-ups have asthma, contrasted with 6.2% of male grown-ups. It is the most common chronic illness in children. Presently, there are around 4.8 million kids younger than 18 with asthma in 2022. The prevalence of asthma is increasing, and it is estimated that the number of people with the disease will continue to rise in the coming years due to factors such as air pollution, obesity, and allergies. Thus, the surge in the incidences of asthma have a positive impact on the growth of the market.
• Based on end-user, the market is segmented into hospitals & clinics, emergency centers, and home use. The hospitals & clinics held the dominant share of the market in 2021 owing to the presence of therapeutic and critical care products. Moreover, the presence of skilled professionals who are responsible for developing and implementing treatment plans for patients with respiratory disorders. In 2022, asthma will be the cause of 439,000 hospital admissions and 1.3 million visits to the emergency room, according to the CDC. Thus, these above-mentioned factors are driving the growth of the segment in the forecast period.
• For a better understanding of the market adoption of the dental clensing tablet industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia Pacific is anticipated to grow with high CAGR during the forthcoming period. The growing demand for vibrating mesh nebulizers can be attributed due to increased air pollution and the burden on medical care administrations because of the expanded number of instances of COPD and asthma. Also, more vibrating mesh nebulizers are being utilized to oversee COPD and asthma, further driving the market development appropriately. In addition, the Asia-Pacific region is seeing an increase in both the rate of urbanization and the number of people suffering from respiratory conditions.
• Some of the major players operating in the market include Aerogen; APEX MEDICAL CORP.; Koninklijke Philips N.V.; OMRON Healthcare, Inc.; HCmed Innovations Co., Ltd.; PARI GmbH; Hamilton Medical; HEALTH & LIFE CO., LTD.; Rossmax International Ltd.; and Briggs Healthcare.